The boundary between skincare and medicine is blurring. Regenerative biotechnology is leading the charge, moving beyond surface-level hydration to actual cellular repair.
Exosomal Signaling
The headline tech of 2026 is the refined use of exosomes—tiny vesicles that act as the skin's biological messenger system. By programming these messengers, we can now signal the skin to produce collagen at rates previously only possible via clinical procedures.
Glow Protocol's laboratory partners are currently calibrating the first retail-ready stable exosome serum for high-fidelity home use.